Opportunities to present our products and technologies and also to better understand the needs of healthcare professionals and patients.
Paris, France
Cardiawave was selected to participate to the Jon DeHaan Foundation Award Competition during EuroPCR Innovators’ Day next week! The Jon DeHaan Foundation provides funding to individuals and companies focused on commercializing innovative developments in cardiovascular medicine; this award would be a great opportunity for Cardiawave to promote the advances and results of its innovative non-invasive ultrasound therapy for the treatment of calcific aortic stenosis. Please join us for our oral presentation on May 15, 2023, during the Jon DeHaan Foundation Award Competition, at Theatre Havane, from 4:30 PM to 5:10 PM CET!
Palais de la Bourse, Lyon, France
Cardiawave participated in the 2nd edition of the #HIFUture symposium, on April 21st, 2023 at the Palais de la Bourse in Lyon, France, dedicated to the ultrasound treatments of tomorrow.
Prof. Emmanuel Messas presented the latest clinical results regarding our innovative solution for the treatment by non-invasive ultrasound therapy (NIUT) of calcific aortic stenosis, during the “Clinical Innovations” session between 3:30PM to 5:30PM.
This event was an opportunity for us to share our experience and discuss with other experts and professionals in the healthcare industry.
Thanks to LabTAU, Inserm U1032 and Hospices Civils de Lyon Civils de Lyon for the organization!
Palais de la Bourse, Lyon, France
Our Ultrasound R&D Lead Engineer Wojciech Kwiecinski presented at the combined 22nd Annual International Symposium on Therapeutic Ultrasound and 6th European Symposium of EUFUS!
This event brings together leading researchers, scientists, and practitioners from around the world to share the latest advances in therapeutic ultrasound. We were honored to have Wojciech present our cutting-edge technology and research alongside some of the most innovative minds in the industry.
Wojciech presented on “Non-invasive focused ultrasound therapy of calcific aortic stenosis: 40 patients, 12-months follow-up of Valvosoft® FIH Studies” on Tuesday April 18th at 2:16 PM (Salle Ampère) in Palais de la Bourse, Place de la Bourse, 69002 in Lyon, France, Salle Ampère.
We would like to express our gratitude to the organizers of the symposium for giving us the opportunity to showcase our work and to share our passion for advancing the field of therapeutic ultrasound.
Cité des Sciences et de l’Industrie, Paris, France
Notre Directeur des Opérations Maurice Delplanque était présent à la 8ème édition de la « Journée start-up innovantes du dispositif médical », organisé par le SNITEM, le Syndicat National de l’Industrie des Technologies Médicales.
Cet événement, qui a eu lieu le mardi 4 avril 2023 à la Cité des Sciences et de l’Industrie, Paris 19e, rassemble les acteurs clés du secteur de la santé pour découvrir et échanger sur les dernières innovations en matière de dispositifs médicaux. Nous y avons rencontré les professionnels de la santé présents et de partager notre vision de l’avenir du domaine de la cardiologie avec notre traitement innovant et non-invasif par ultrasons de la sténose aortique. Cet événement nous a donné l’opportunité d’en apprendre davantage sur les tendances du marché et de rencontrer des acteurs clés de l’industrie.
Nous tenons à remercier le SNITEM pour l’organisation de cet événement, ainsi que toutes les personnes impliquées dans sa préparation.
Ecole de Physique, les Houches, France
Our PhD student Clara Magnier has participated this week to the Winter School on Therapeutic Ultrasound, at the School of Physics of les Houches in France.
Clara presented yesterday (March 23, 2023) the “Optimization of ultrasonic shock waves for the non-invasive heart therapy”, during student presentation. Thanks to Jean-François Aubry (Physmed), Gail ter Haar (Institute of Cancer Research) and Vera Khokhlova (LIMU/CIMU) for the organization !
Palais des Congrès, Paris, France
Cardiawave is attending one of the major European scientific and medical annual symposium JESFC 2023 featuring major medical research breakthroughs.
Leading researchers and clinicians will be discussing the latest evidence-based research.
JESFC provides cardiologists and other cardiovascular healthcare professionals with everything they need to improve patient outcomes.
Prof. Emmanuel Messas HEGP Hôpital Européen Georges-Pompidou (AP-HP, Assistance Publique – Hôpitaux de Paris ) will be the speaker for the ‘Non-invasive treatment of severe symptomatic aortic stenosis with ultrasound’ presentation sponsored by Cardiawave during the session : ‘Thérapeutiques du futur’ on Friday, January 13th, 2023 at 10:20 AM, Room: Amphithéâtre Bleu.
He will present our non-invasive therapy, our device and our latest clinical results.
Thank you SFC – Société Française de Cardiologie and moderators, Dominique BABUTY and Pr Michel S. SLAMA !
Institut Pasteur, Paris, France
Que fait-on des innovations technologiques en santé ?
Arrivent-elles toujours au patient ? Dans quel délai ? Partout en France ?
Benjamin BERTRAND – CEO Cardiawave – co-intervenant de la table ronde à 11h30 sur ” l’echo thérapie, des technologies de moins en moins invasives” à la base de nombreux dispositifs médicaux qui apportent des solutions thérapeutiques nouvelles, qui améliorent la qualité de vie des patients et une réponse au système de soin, en souffrance.
Benjamin partagera son expérience et s’appuiera sur les résultats prometteurs des études cliniques actuellement en cours avec le dispositif médical de thérapie non-invasive par ultrasons, développé par Cardiawave, pour le traitement de la sténose aortique : traitement de patients aujourd’hui sans solution médicale, absence de chirurgie, courte durée d’hospitalisation, réduction des coûts etc.
Pour Benjamin et ses co-intervenants CEO de medtech, il est urgent d’accélérer l’accès des innovations technologiques en santé pour les patients, les médecins et pour la société en général.
Boston, USA
Our CEO, Benjamin Bertrand, attended the TCT 2022 event, in Boston, from September 16-19. It was a good opportunity for Cardiawave to be there!
Paris, France
Cardiawave attended Vivatech 2022 from June 15-18, in Paris Expo Porte de Versailles. Come and meet us at booth J59! Thanks to CNRS for this opportunity.
Online
Cardiawave attended virtually attending the 2022 LSX World Congress.
Dublin, Ireland
Cardiawave attended the Innovation Summit 22 in Dublin, Ireland, by Medtech Strategist. It had been an opportunity to connect with investors and partners.
Paris
Prof. Messas from HEGP (APHP) presented how to treat aortic stenosis with Focused Ultrasound at Académie Nationale de Chirurgie.
Thanks for such an opportunity!
Online
Cardiawave attended the Emerging Medtech Summit 2022 organized by LSI Intelligence.
Online
Our CEO Benjamin Bertrand virtually attended the RESI Conference from January 11–13, 2022.
Online
Online
Online
Cardiawave attended the AHA Scientific Sessions 2021 from November 13-15. Prof. Emmanuel Messas from HEGP presented our Non-Invasive Ultrasound Therapy (NIUT) in Patients With Severe Symptomatic Aortic Valve Stenosis.
Digital edition – Jonathan Halim
Cardiawave attended the TCT event (Cardiovascular Research Foundation) from November 4-6. Dr. Jonathan Halim from Amphia hospital presented our Non-Invasive Ultrasound Therapy (NIUT) in low-flow, low-gradient severe aortic stenosis at session TCT 47 on November 04 at 8:19 AM. It was a real pleasure for us to participate in this event!
Digital edition – Emmanuel Messas
Prof. Emmanuel Messas presented at European Society of Cardiology (August 27-30), a poster regarding updated clinical results of Cardiawave on-going First-In-Human clinical studies.
Digital edition – Emmanuel Messas
Digital edition – Emmanuel Messas
Digital edition – Wojciech Kwiecinski
Digital edition – Emmanuel Messas
Digital edition – Emmanuel Messas
Prof. Emmanuel Messas presented our latest results during ESC Congress 2020 in September 2020, in an abstract entitled « Safety, feasibility and performance of Valvosoft non-invasive ultrasound therapy in patients with severe symptomatic calcific aortic valve stenosis ».
Digital edition – Daniel Suarez
Our R&D Ultrasound Engineer, Daniel Suarez Escudero, presented our FirstInMan study at IEEEIUS 2020, in Thursday 10 September 2020, at 19:30 (UTC+2). Title of the presentation : Non-Invasive Focused Ultrasound Therapy of Calcified AorticStenosis: First-In-Man Study.
Digital edition – Sander Ijsselmuiden
Washington DC – Emmanuel Messas
Tel Aviv – Emmanuel Messas
Philadelphia – Emmanuel Messas
San Francisco – Peter den Heijer